ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 198 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $43,696,000 | +8.9% | 3,512,570 | +19.9% | 0.04% | +5.9% |
Q3 2016 | $40,112,000 | +1038.9% | 2,930,036 | +514.8% | 0.03% | +1033.3% |
Q2 2016 | $3,522,000 | +61.0% | 476,585 | +39.3% | 0.00% | +50.0% |
Q1 2016 | $2,187,000 | +13.0% | 342,185 | +10.5% | 0.00% | 0.0% |
Q4 2015 | $1,936,000 | +7.0% | 309,785 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $1,809,000 | -29.5% | 309,785 | -0.1% | 0.00% | 0.0% |
Q2 2015 | $2,565,000 | +0.4% | 310,155 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $2,556,000 | +19.9% | 310,155 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $2,131,000 | +27.2% | 310,155 | 0.0% | 0.00% | +100.0% |
Q3 2014 | $1,675,000 | -15.2% | 310,155 | 0.0% | 0.00% | -50.0% |
Q2 2014 | $1,976,000 | +115.5% | 310,155 | +172.6% | 0.00% | +100.0% |
Q1 2014 | $917,000 | +30.8% | 113,756 | +10.7% | 0.00% | 0.0% |
Q4 2013 | $701,000 | -86.5% | 102,767 | -63.6% | 0.00% | -80.0% |
Q3 2013 | $5,199,000 | +11.0% | 282,539 | +5.5% | 0.01% | 0.0% |
Q2 2013 | $4,684,000 | – | 267,810 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
Geduld E E | 272,200 | $1,470,000 | 1.04% |
Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |